PPBT

NASDAQ 已收盘

Purple Biotech

1.53 USD
▼-0.01-0.33%
盘后 1.53 +0.33%
2026-11-20
市值
$10.49M
市盈率
—
EPS
-6.54
股息率
—
52 周区间
0.91 – 8.90
成交量
21.67K
Beta
-0.58
目标价
—
52W 低 0.9152W 高 8.90
价格走势

公司简介

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin recept...